Erector spinae plane block
Not Applicable
Completed
- Conditions
- Anaesthesia
- Registration Number
- PACTR201807214613900
- Lead Sponsor
- Faculty of Medicine Tanta university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
adult patients
-either gender
-scheduled for percutaneous radiofrequency ablation of primary or secondary hepatic tumors
Exclusion Criteria
-patients with a child-pugh score more than B7
-INR more than1.5
-platelet count less than 50000/mm3
-history of mental disorders
-allergy to local anesthetics
-chest wall deformity
-regular use of analgesics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie erector spinae plane block (ESPB) analgesia during liver tumor ablation?
How does ultrasound-guided ESPB compare to paravertebral block for postoperative pain management in liver tumor radiofrequency ablation?
Which biomarkers correlate with successful pain control following ESPB in hepatic tumor interventions?
What are the adverse event profiles of ESPB versus general anesthesia in percutaneous liver tumor ablation?
Are there adjuvant agents or combination therapies enhancing ESPB efficacy for hepatic tumor procedures?